Client login

Clinical Services / Minimizing Risk And Maximizing Efficiency By Taking A Strategic Approach To Comparative Trial Supply

Publication

Back

Minimizing Risk And Maximizing Efficiency By Taking A Strategic Approach To Comparative Trial Supply

Widely acknowledged to be a prerequisite for formulary listing and even successful licensure, comparator drugs and co-therapies are used within an estimated two-thirds of clinical trials. Nicholas Griffin at Almac Clinical Services evaluates how to minimize risk and increase efficiency when taking a strategic approach to comparative trial supply.

Read more on this article by clicking here.

Our Expert

Nicholas Griffin, Global Commercial Product Procurement Manager, Craigavon, Almac Clinical Services

Almac Clinical Services

Guided by our extensive clinical supply experience and expertise, Almac Clinical Services is recognized as an innovative, global solution provider within the specialized and complex market of clinical trial supply.

Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.

Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.

Learn More

You may also be interested in

Article

Using Managed Access Programs to better manage post-trial treatment access

Margaret Radford

Article

Having the ultimate streamlined system to manage the temperature data of your clinical

Sarah McAliskey

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Download here instantly

Using Managed Access Programs to better manage post-trial treatment access

Having the ultimate streamlined system to manage the temperature data of your clinical